Trulicity

Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
television ads
pharma marketing
DTC ads
AbbVie
Rinvoq
Dupixent
Sanofi
Regeneron
Skyrizi
Novo Nordisk
Ozempic
Jardiance
Eli Lilly
Boehringer Ingelheim
Rybelsus
Trulicity
Rexulti
Otsuka
Lundbeck
Tremfya
JNJ
Verzenio
Flag link:
Eli Lilly diabetes drugs Mounjaro and Trulicity in short supply, FDA says
Eli Lilly diabetes drugs Mounjaro and Trulicity in short supply, FDA says
Medical Marketing and Media
Eli Lilly
diabetes
drug shortages
Mounjaro
Trulicity
Flag link:
Novo Nordisk snags high-dose Ozempic approval, turning up the heat on Lilly's Trulicity
Novo Nordisk snags high-dose Ozempic approval, turning up the heat on Lilly's Trulicity
Fierce Pharma
Novo Nordisk
Ozempic
diabetes
FDA
Eli Lilly
Trulicity
Flag link:
Trulicity Instagram post draws OPDP’s first untitled letter of 2022
Trulicity Instagram post draws OPDP’s first untitled letter of 2022
RAPS.org
Eli Lilly
Trulicity
OPDP
FDA
social media
Flag link:
As Lilly gears up for key 2022 launches, Trulicity, Taltz and more drive solid growth
As Lilly gears up for key 2022 launches, Trulicity, Taltz and more drive solid growth
Fierce Pharma
Eli Lilly
earnings
Trulicity
Taltz
Verzenio
Emgality
Flag link:
The top 15 blockbuster patent expirations coming this decade
The top 15 blockbuster patent expirations coming this decade
Fierce Pharma
patents
patent cliff
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Revlimid
Pfizer
Eliquis
Regeneron
Eylea
JNJ
Stelara
Opdivo
GSK
Dolutegravir
Ibrance
Januvia
Eli Lilly
Trulicity
Novo Nordisk
Victoza
Amgen
Prolia
Xgeva
Novartis
Cosentyx
Takeda
Entyvio
Flag link:
Lilly warms up for Olympics with Team USA athletes in ads for Trulicity, Emgality and Verzenio
Lilly warms up for Olympics with Team USA athletes in ads for Trulicity, Emgality and Verzenio
Fierce Pharma
Eli Lilly
pharma marketing
Olympics
Trulicity
Emgality
Verzenio
Flag link:
ADA 2021: Novo trumpets higher-dose Ozempic data as Lilly competitors loom
ADA 2021: Novo trumpets higher-dose Ozempic data as Lilly competitors loom
Fierce Pharma
Novo Nordisk
Ozempic
Eli Lilly
Rybelsus
Trulicity
diabetes
type 2 diabetes
Flag link:
Eli Lilly wraps up fifth and final tirzepatide PhIII trial, claiming a win over Sanofi's Lantus. The FDA awaits
Eli Lilly wraps up fifth and final tirzepatide PhIII trial, claiming a win over Sanofi's Lantus. The FDA awaits
Endpoints
Eli Lilly
diabetes
Trulicity
tirzepatide
clinical trials
Flag link:
Pharma TV Ad Spending Trends: Companies in the Top Ten this Week
Pharma TV Ad Spending Trends: Companies in the Top Ten this Week
Xtalks
DTC ads
television ads
Dupixent
Trulicity
Rybelsus
Flag link:
Insider alleges Eli Lilly blocked her efforts to sound alarms about U.S. drug factory
Insider alleges Eli Lilly blocked her efforts to sound alarms about U.S. drug factory
Reuters
Eli Lilly
drug manufacturing
Trulicity
Flag link:
ADA: Lilly's Trulicity tops Ozempic at keeping patients compliant, real-world data show
ADA: Lilly's Trulicity tops Ozempic at keeping patients compliant, real-world data show
Fierce Pharma
ADA
diabetes
Eli Lilly
Trulicity
Novo Nordisk
Ozempic
Flag link:
Trulicity gets FDA nod for reducing CV risk in type 2 diabetes patients
Trulicity gets FDA nod for reducing CV risk in type 2 diabetes patients
Pharmaceutical Business Review
Eli Lilly
Trulicity
FDA
type 2 diabetes
Cardiovascular
Flag link:
How a cocktail of existing drugs could regenerate insulin-producing cells in diabetes
How a cocktail of existing drugs could regenerate insulin-producing cells in diabetes
Fierce Biotech
diabetes
insulin
Mt Sinai
Novo Nordisk
Ozempic
Rybelsus
Victoza
Eli Lilly
Trulicity
AstraZeneca
Bydureon
Flag link:
Lilly’s diabetes med Trulicity shrugs off Novo Nordisk challenge
Lilly’s diabetes med Trulicity shrugs off Novo Nordisk challenge
Pharmaforum
Eli Lilly
Trulicity
diabetes
Flag link:
Lilly counts on growing markets to boost lagging Taltz, Trulicity
Lilly counts on growing markets to boost lagging Taltz, Trulicity
Fierce Pharma
Eli Lilly
Trulicity
Taltz
immunology
type 2 diabetes
Flag link:
How Big Can This $8 Billion-Plus Diabetes Drug Class Get?
How Big Can This $8 Billion-Plus Diabetes Drug Class Get?
Motley Fool
diabetes
Eli Lilly
Merck
Novo Nordisk
GSK
Byetta
Victoza
Bydureon
Ozempic
Tanzeum
Trulicity
Rybelsus
Flag link:
How This Pharma Stock Could Knock Eli Lilly Off Its Diabetes Pedestal
How This Pharma Stock Could Knock Eli Lilly Off Its Diabetes Pedestal
Investors Business Daily
Novo Nordisk
Eli Lilly
oral semaglutide
Trulicity
diabetes
Flag link:
Lilly's Study on Higher Doses of Trulicity Meets Endpoint
Lilly's Study on Higher Doses of Trulicity Meets Endpoint
Yahoo/Zacks.com
Eli Lilly
clinical trials
type 2 diabetes
Trulicity
Flag link:
ADA: Lilly's Trulicity cuts heart risks by 12%. Is it enough to fend off semaglutide?
ADA: Lilly's Trulicity cuts heart risks by 12%. Is it enough to fend off semaglutide?
Fierce Pharma
Eli Lilly
ADA
diabetes
heart attack
stroke
Trulicity
Novo Nordisk
semaglutide
Flag link:

Pages